Based on our records, the NDC code you provided is eligible for Iowa. You are likely eligible for one or more Economic Loss subclasses. You may also be eligible for the Medical Monitoring Class/Subclass shown below. If you wish to exclude yourself from the lawsuit and forego any future benefits, but also forego being bound by any adverse judgments, click here. If you wish to remain in the lawsuit and receive any potential future benefits, you do not need to take action, but you can choose to register for updates. No benefits are available at this time. You must complete and timely submit a claim form to receive benefits, if and when benefits are available. Please check this website regularly for updates.
23(b)(2) Medical Monitoring (Physical Injury Required) Remedy Subclass
All individuals residing in Alabama; Connecticut; Delaware; Georgia; Illinois; Iowa; Kentucky; Louisiana; Michigan; Nebraska; Oklahoma; Oregon; and Wisconsin who consumed a sufficiently high Lifetime Cumulative Threshold of NDMA or NDEA, in generic valsartan-containing drugs manufactured by or for Defendants and marketed in the United States and its territories and possessions, at least since January 1, 2012. Excluded from this Class are the following: (i) Defendants and their subsidiaries and affiliates; (ii) All persons who make a timely election to be excluded from the Classes; (iii) Governmental entities; and (iv) Any judicial officers who preside over this case and their immediate family members. Also excluded from the Classes are those consumers of Valsartan-Containing Drugs who have been diagnosed with cancers allegedly as a result of taking Defendants’ Valsartan-Containing Drugs containing NDMA or NDEA.